Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: Prescription rate, predictors, and prognostic value

American Heart Journal

Volumn 159, Issue 6, 2010, Pages 1012-1019

  Lee, Jang Hoon ^a   Yang, Dong Heon ^a   Park, Hun Sik ^a   Cho, Yongkeun ^a   Jeong, Myung Ho ^b   Kim, Young Jo ^c   Kim, Kee Sik ^d   Hur, Seung Ho ^e   Seong, In Whan ^f   Hong, Taek Jong ^g   Cho, Myeong Chan ^h   Kim, Chong Jin ⁱ   Jun, Jae Eun ^a   Park, Wee Hyun ^a   Chae, Shung Chull ^a  

^a Kyungpook National University Hospital   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Young Nam University Hospital   (South Korea)

^d Catholic University of Daegu   (South Korea)

^e Dongsan Medical Center   (South Korea)

^f Chungnam National University College of Medicine   (South Korea)

^g Pusan National University Hospital   (South Korea)

^h Chungbuk National University Hospital   (South Korea)

ⁱ Kyung Hee University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; ANGIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL CLASSIFICATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DISEASE REGISTRY; DRUG CONTRAINDICATION; EVIDENCE BASED MEDICINE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KOREA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRESCRIPTION DRUGS; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; SURVIVAL RATE;

EID: 77953076299     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.03.009     Document Type: Article

References (24)

1. Tunstall-Pedoe H., Vanuzzo D., Hobbs M., et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 355 (2000) 688-700
2. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116 (2007) e148-e304
3. Antman E.M., Hand M., Armstrong P.W., et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 117 (2008) 296-329
4. Mukherjee D., Fang J., Chetcuti S., et al. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 109 (2004) 745-749
5. Yan A.T., Yan R.T., Tan M., et al. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. Am Heart J 154 (2007) 1108-1115
6. Granger C.B., Steg P.G., Peterson E., et al. Medication performance measures and mortality following acute coronary syndromes. Am J Med 118 (2005) 858-865
7. Krumholz H.M., Radford M.J., Ellerbeck E.F., et al. Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes. Ann Intern Med 124 (1996) 292-298
8. Allison J.J., Kiefe C.I., Weissman N.W., et al. Relationship of hospital teaching status with quality of care and mortality for medicare patients with acute MI. JAMA 284 (2000) 1256-1262
9. Burwen D.R., Galusha D.H., Lewis J.M., et al. National and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999: the Medicare health care quality improvement program. Arch Intern Med 163 (2003) 1430-1439
10. Chen J., Radford M.J., Wang Y., et al. Do "America's best hospitals" perform better for acute myocardial infarction?. N Engl J Med 340 (1999) 286-292
11. Kohro T., Hayashi D., Okada Y., et al. Effects of medication on cardiovascular events in the Japanese coronary artery disease (JCAD) study. Circ J 71 (2007) 1835-1840
12. Lee J.H., Park H.S., Chae S.C., et al. Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Am J Cardiol 104 (2009) 182-189
13. Alpert J.S., Thygesen K., Antman E., et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
14. Pristipino C., Beltrame J.F., Finocchiaro M.L., et al. Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. Circulation 101 (2000) 1102-1108
15. Spencer F.A., Lessard D., Yarzebski J., et al. Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction. Am Heart J 150 (2005) 838-844
16. Roe M.T., Peterson E.D., Newby L.K., et al. The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J 151 (2006) 1205-1213
17. Alexander K.P., Roe M.T., Chen A.Y., et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 46 (2005) 1479-1487
18. Yan R.T., Yan A.T., Tan M., et al. Age-related differences in the management and outcome of patients with acute coronary syndromes. Am Heart J 151 (2006) 352-359
19. Simpson E., Beck C., Richard H., et al. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Am Heart J 145 (2003) 438-444
20. Rathore S.S., Mehta R.H., Wang Y., et al. Effects of age on the quality of care provided to older patients with acute myocardial infarction. Am J Med 114 (2003) 307-315
21. Krumholz H.M., Radford M.J., Wang Y., et al. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 280 (1998) 623-629
22. Ray K.K., Bach R.G., Cannon C.P., et al. Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS. Eur Heart J 27 (2006) 2310-2316
23. Shepherd J., Blauw G.J., Murphy M.B., et al. PROspective Study of Pravastatin in the Elderly at Risk. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360 (2002) 1623-1630
24. Bhatt D.L., Roe M.T., Peterson E.D., et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes (results from the CRUSADE quality improvement initiative). JAMA 292 (2004) 2096-2104